Australia markets close in 45 minutes

ageas SA/NV (AGESY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
52.53+0.42 (+0.81%)
At close: 03:51PM EST
Full screen
Trade prices are not sourced from all markets
Previous close52.11
Bid0.00 x 0
Ask0.00 x 0
Day's range52.30 - 52.65
52-week range45.17 - 67.11
Avg. volume9,075
Market cap9.768B
Beta (5Y monthly)0.81
PE ratio (TTM)12.17
EPS (TTM)4.32
Earnings dateN/A
Forward dividend & yield5.99 (11.05%)
Ex-dividend date02 June 2021
1y target est61.49
  • GlobeNewswire

    Ageas reports on the progress of share buy-back programme

    Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 11 August 2021, Ageas reports the purchase of 98,844 Ageas shares in the period from 29-11-2021 until 03-12-2021. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)29-11-202115,300719,25847.0146.6847.2430-11-202130,2801,377,78645.5044.9045.9901-12-20213,806180,11747.3246.1347.7102-12-20214,158197,33847.4647.0147.8503-12-202145,300

  • GlobeNewswire

    Ageas and Schroders plc: Transparency notification

    Ageas and Schroders plc: Transparency notification In accordance with the rules on financial transparency*, Schroders plc has notified Ageas on 16 November 2021 that, on 15 November 2021, its interest has exceeded the statutory threshold of 3% of the shares issued by Ageas. Its current shareholding stands at 3.02%. Reason for the notificationAcquisition or disposal of voting securities or voting rights Notification byA parent undertaking or a controlling person Persons subject to the notificatio

  • GlobeNewswire

    Ageas reports on its nine month results 2021

    Ageas reports on its nine month results 2021 Continued strong commercial performance across the businessExcellent operating performance in both Life and Non-LifeOn track to reach 2021 profit guidance and Connect21 targets Net Result The Group net result was EUR 568 million driven by an excellent performance in Life, but hampered by RPN(i)Insurance net result increased from EUR 737 million to EUR 777 millionNet result in Non-Life amounted to EUR 236 million compared to EUR 311 million in last yea